Genetic Testing · 1999 · 55 citations · 13 references
MedicineGeneticsOncologyCancer GeneticsMedical GeneticsMetastasisCancer GenomicsCancer RiskColorectal CancerGenetic Risk AssessmentMalignant NeoplasmsColorectal Cancer EpidemiologyColorectal Cancer PredispositionExtracolonic Cancer RiskHereditary Cancer RiskLymph Node MetastasesMethylenetetrahydrofolate Reductase PolymorphismsMolecular Risk MarkersMutation
This paper examines whether there is a relationship between a common mutation in the methylenetetrahydrofolate reductase gene, MTHFR*val, and the risk of colorectal cancer, with or without lymph node metastases. MTHFR genotypes were ascertained from peripheral leukocyte samples obtained from 200 colorectal patients, including TMN stages I-VI, and from 460 healthy, unrelated adults without colorectal cancer, who served as controls. The frequency of homozygosity for the MTHFR*val/*val genotype among the colorectal cancer patients was lower (14.0%) than among controls (16.1%). The latter finding results in an estimated MTHFR*val allele frequency of 0.41. The MTHFR*val allele (677C > T) reduces colorectal risk slightly [odds ratio (OR), 0.87]. However, there was a significantly higher incidence of metastatic lymph nodes per case in MTHFR*val/*val patients, when compared with MTHFR*ala/*ala controls (6.9 +/- 1.55 vs. 3.7 +/- 0.57, p = 0.003). These results suggest that the MTHFR genotype might be of prognostic significance in colorectal carcinoma.
13
Hypomethylation of DNA from Benign and Malignant Human Colon Neoplasms
Susan Goelz, Bert Vogelstein, Stanley R. Hamilton et al. · Science · 1985 · 838 citations
Jing Ma, Meir J. Stampfer, Edward L. Giovannucci et al. · PubMed · 1997 · 794 citations
Homocysteine metabolism in pregnancies complicated by neural-tube defects
James L. Mills, Yeon‐Joo Lee, M.R. Conley et al. · The Lancet · 1995 · 646 citations